<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01055093</url>
  </required_header>
  <id_info>
    <org_study_id>GDC-Study-01</org_study_id>
    <nct_id>NCT01055093</nct_id>
  </id_info>
  <brief_title>Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients</brief_title>
  <acronym>GDC</acronym>
  <official_title>Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>German Diabetes Center</source>
  <brief_summary>
    <textblock>
      The aim of the prospective observational GDC-Study in patients with newly diagnosed diabetes
      mellitus aged 18-69 years at inclusion into the study is to characterize in detail the
      clinical, metabolical and immunological phenotype and monitor the progression of the disease
      and to compare the phenotype to glucose tolerant humans of similar age, body mass and sex
      distribution.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In detail, the following questions will be answered:

        1. Are there different phenotypes with respect to insulin secretion, insulin sensitivity,
           micro- and macrovascular status and diabetic neuropathy at time of diagnosis?

        2. Which factors modify the progression of the disease (Nutrition, subclinical
           inflammation, energy metabolism and physical activity)?

        3. Can we identify subgroups at baseline with different progression of the disease?
           Patients are thoroughly examined at baseline and after 2, 5, and 10 years with annual
           telephone contacts in between.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2005</start_date>
  <completion_date type="Anticipated">September 2035</completion_date>
  <primary_completion_date type="Anticipated">September 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of insulin sensitivity (M-Value)</measure>
    <time_frame>2 and 5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of insulin secretion</measure>
    <time_frame>2 and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of any diabetic complication</measure>
    <time_frame>2-10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Diabetes Cohort</arm_group_label>
    <description>Prospectively followed cohort of newly diagnosed patients with diabetes mellitus, aged 18-69 years at inclusion into the study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Cohort</arm_group_label>
    <description>Prospectively followed cohort of glucose tolerant humans, aged 18-69 years at inclusion into the study</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, PBMC, serum, plasma, urine, stool
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients are recruited from the general populations by screening
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of diabetes mellitus according to ADA criteria

          -  Age 18-69

          -  Diabetes duration since diagnosis &lt; 12 months

          -  Control cohort: proven normal glucose tolerance according to ADA criteria

        Exclusion Criteria:

          -  Diabetes mellitus category 3 B-H (ADA criteria)

          -  Pregnancy

          -  Severe renal, liver or heart disease

          -  malignant cancer

          -  severe psychiatric illness or addiction

          -  participation in an intervention trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Roden, Prof., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>German Diabetes Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julia Szendrödi, MD</last_name>
    <phone>+49-211-3382-0</phone>
    <phone_ext>-209</phone_ext>
    <email>studienzentrum@ddz.uni-duesseldorf.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Petra Heidkamp</last_name>
    <phone>+49-211-3382-0</phone>
    <phone_ext>-209</phone_ext>
    <email>studienzentrum@ddz.uni-duesseldorf.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>German Diabetes Center</name>
      <address>
        <city>Düsseldorf</city>
        <state>North-Rhine Westphalia</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Study Center</last_name>
      <phone>+49-211-3382-0</phone>
      <phone_ext>-209</phone_ext>
      <email>studienzentrum@ddz.uni-duesseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Michael Roden, Prof., MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dan Ziegler, Prof., MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Herder, PhD, M.Sci.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wolfgang Rathmann, MD, MSPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Icks, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joachim Rosenbauer, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jörg Kotzka, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://ddz.uni-duesseldorf.de/index.html</url>
    <description>Official website of the German Diabetes Center</description>
  </link>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2010</study_first_submitted>
  <study_first_submitted_qc>January 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2010</study_first_posted>
  <last_update_submitted>September 11, 2017</last_update_submitted>
  <last_update_submitted_qc>September 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>German Diabetes Center</investigator_affiliation>
    <investigator_full_name>julia szendrödi</investigator_full_name>
    <investigator_title>Dr. Julia Szendrödi</investigator_title>
  </responsible_party>
  <keyword>diabetes mellitus</keyword>
  <keyword>prospective observational study</keyword>
  <keyword>diabetic complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

